My watch list  

Agilent Technologies to introduce genomics technology into India's growing life sciences market


Agilent Technologies Inc. announced plans to introduce its DNA microarray-based genomics solutions into India's growing life sciences market. Agilent currently sells technologies for the chemical, environmental and pharmaceutical manufacturing markets in India, and is a biotech leader there. The company expects to expand its presence into industries such as medical research, drug discovery and agro-biotech.

"Agilent's Life Sciences and Chemical Analysis business had double-digit growth in India last year, driven by the country's booming biotechnology, agriculture, information technology and pharmaceuticals industries," said Sanjeev Dhar, country manager for the LSCA business in India. "India is now LSCA's fourth-largest country of business in Asia, and one of the fastest-growing. We expect this growth to continue as we launch our industry-leading solutions for the life sciences sector into areas such as genomics and proteomics research."

The Indian microarray market is estimated to grow by approximately 70 percent in 2005, according to genomics and bioinformatics company Genotypic.

Agilent's life science technologies address demand from government-funded research institutions and pharmaceutical companies -- a demand expected to be fueled by the Indian government's Draft National Biotechnology Policy. The strategy focuses on using biotechnology as a tool to improve quality of life and aims to position India as a worldwide hub for biotechnology research. A government-supported infrastructure is expected to stimulate research in areas such as genomics, stem cells, molecular medicine, metabolic engineering and cell biology.

More about Agilent
  • News

    Agilent to Acquire BioTek

    Agilent Technologies Inc. announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion. The transaction is expected to be compl ... more

    Agilent Expands Portfolio in Cell Analysis

    Agilent Technologies Inc. announced it has signed a definitive agreement to acquire privately-owned ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis instruments for life science research and clinical diagnostics, for $250 million in cash. “Expanding our cell analysis ... more

    Agilent completes acquisition of Young In Scientific assets

    Agilent Technologies Inc. announced that it has completed its acquisition of the Agilent-related business from Young In Scientific Co. Ltd. and its affiliates (“YI Scientific”). YI Scientific is a distributor of analytical and scientific instruments in South Korea and a long-time distributo ... more

  • Companies

    Agilent Technologies Sales & Services GmbH & Co. KG

    Agilent Technologies in Waldbronn develops, produces and markets market-leading complete analytical solutions, based on liquid chromatography, electrophoresis and microfluidics. Our instruments, software and sample preparation solutions help scientists to research faster and more accurately. more

More about Genotypic Technology P
  • News

    Agilent Technologies Expands Genomics Network in Asia Pacific

    Agilent Technologies Inc. announced that it has signed five distributors to sell and distribute genomics products for microarray analysis. The distributors service India, Indonesia, Korea, Hong Kong, China and Australia. In addition, Agilent has expanded its Certified Service Provider netwo ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE